Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention?
ACTION Coeur Research Group, Institut de Cardiologie, Assistance Publique Hôpitaux de Paris (APHP), Sorbonne Universités, (UPMC), INSERM, UMR_S 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases , Paris, France (http://www.action-coeur.org/).
Johanne
J
Silvain
ACTION Coeur Research Group, Institut de Cardiologie, Assistance Publique Hôpitaux de Paris (APHP), Sorbonne Universités, (UPMC), INSERM, UMR_S 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases , Paris, France (http://www.action-coeur.org/).
Jean-Philippe
JP
Collet
ACTION Coeur Research Group, Institut de Cardiologie, Assistance Publique Hôpitaux de Paris (APHP), Sorbonne Universités, (UPMC), INSERM, UMR_S 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases , Paris, France (http://www.action-coeur.org/) gilles.montalescot@psl.aphp.fr.
Gilles
G
Montalescot
D058186:Acute Kidney Injury / Q000139:chemically induced*; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D062645:Percutaneous Coronary Intervention
D003287:Contrast Media